Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
about
Clinical significance of T cell metabolic reprogramming in cancerHypoxic control of metastasisCancer as a Proinflammatory Environment: Metastasis and CachexiaTargeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor ImmunityIntertwined regulation of angiogenesis and immunity by myeloid cellsTargeting Immune Regulatory Networks to Counteract Immune Suppression in CancerPHD2: from hypoxia regulation to disease progressionTargeting tumor-associated macrophages to combat pancreatic cancerPro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic TargetsThe unfolded protein response in immunity and inflammationSunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumoursAnthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach.New insights into the role of EMT in tumor immune escape.Metformin inhibits gastric cancer via the inhibition of HIF1α/PKM2 signalingA 3D-Printed Oxygen Control Insert for a 24-Well Plate.Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas--an immunohistochemical study.Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.Hyperbaric oxygen therapy sensitizes nimustine treatment for glioma in mice.Crosstalk between the HIF-1 and Toll-like receptor/nuclear factor-κB pathways in the oral squamous cell carcinoma microenvironmentMonocytic myeloid-derived suppressor cells as a potent suppressor of tumor immunity in non-small cell lung cancer.Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs.Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors.Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.Myeloid-derived suppressor cells as effectors of immune suppression in cancer.Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α.Hypoxia and antitumor CD8+ T cells: An incompatible alliance?Hypoxia: A Double-Edged Sword in Cancer Therapy.Myeloid-derived suppressor cells and their role in pancreatic cancer.Role of tumour-associated macrophages in oral squamous cells carcinoma progression: an update on current knowledge.Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane.Macrophages Reprogrammed In Vitro Towards the M1 Phenotype and Activated with LPS Extend Lifespan of Mice with Ehrlich Ascites CarcinomaGLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.Identification of inhibitors of myeloid-derived suppressor cells activity through phenotypic chemical screening.Informatics for cancer immunotherapy.Breathing New Life Into Hypoxia-Targeted Therapies for Non-Small Cell Lung Cancer.Potential Utility of FDG PET-CT as a Non-invasive Tool for Monitoring Local Immune Responses.Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment.Emerging role of RUNX3 in the regulation of tumor microenvironment.
P2860
Q26741974-A0518A17-EFD0-4155-B0FF-E9607009F2DEQ26749159-AE5A6DD3-4E40-4524-AB70-3C7D3A324E83Q26778324-C8A8BB94-1CCF-45DC-9523-0A39AD1C6328Q26782201-FD3E7A5D-07AD-4C2D-BDE2-081208BB7A66Q26830418-7025B73B-066F-49EA-B95F-59F58B739B51Q28066486-964442C3-FF1A-492D-8CA9-2EB71695D795Q28069316-745936DF-D27F-4444-8039-E6F86332ADBFQ28076103-D96D4DD4-0195-4CAF-AB51-FF7F8E025523Q28076161-FB4EB0E7-4C87-41E4-B378-5BB762366114Q29248713-F11D68EE-4844-4C4D-9F8A-471A83EBFB98Q33433105-4AF104C8-B197-4F55-AE40-A7AD7AB9A92EQ33618312-B28EFE65-8DE5-46EF-85F7-E3A0BF4F0EA2Q33639714-49C1AC4C-E5F3-4D0A-8A85-DF8F0AF0DD97Q33869781-7BBFEA29-E5AC-4398-AA90-47FB5795CA26Q35758003-5E9F3937-91D4-4B67-9632-02AF1F7D8E75Q35770819-4F176343-D33D-47D9-BCC9-41E3AA2A36E9Q35909590-1C0A9F52-2103-4254-AB60-8C77B00A2449Q36370966-63F7DFA5-885F-4B54-9273-3011E43CAE38Q37429954-152924C1-DF5B-436B-84EB-C2AD70A79213Q37437301-411E9162-7DFF-4470-8C50-10B4F1025685Q37581919-5D121DB0-FBAE-4294-B1A1-7D832D9B149FQ37731479-320F5AB4-44A5-419C-A015-037476DADE20Q38621446-194A6A85-8741-4FD2-864E-421CEAB8071CQ38815399-90BEC16F-2654-475E-B6AA-EA64FA245A08Q38864758-0D556DD6-66C7-449D-B013-D1CA44DDFB18Q38871815-B429B275-538B-448C-AED6-2B0D6BFA8A9AQ38998450-220C4902-B33F-4370-9CA6-8EC52AC5F161Q39002822-42138EAA-96E5-4B95-BDFE-10612EC3EB9AQ39026957-781A50D0-61FC-440D-A35F-6C0673D9FE6EQ39222608-8CA5CA86-3884-4914-BC71-29F66CEB7196Q39415253-E3B85833-57E6-48C1-9B23-2E79440DCD7BQ40987646-F8CC7ED1-5EDB-4BEB-A961-B776C4BF078DQ41213052-400AACAB-FDCE-48B2-9F1F-C25414B56B56Q42315418-B8BE92E1-8280-4237-A388-B0D67211930CQ45160017-80F85484-840A-4D8B-88AF-E57C82874B3FQ47290509-D66E1858-72F2-43FF-94C5-97D87E164A47Q47769984-6B1070C2-D0E4-4793-BF52-F9FFFC014EE6Q48306408-B64C92A1-F207-4D2C-B015-5ACD8A39B93DQ49725890-31517873-AE6C-46FD-89B7-E87EFF7ED194Q50077138-AB09798E-C30D-4711-A3A2-DEE541C5F3CE
P2860
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
@en
type
label
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
@en
prefLabel
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
@en
P2860
P356
P1433
P1476
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.
@en
P2093
Dmitry I Gabrilovich
Vinit Kumar
P2860
P304
P356
10.1111/IMM.12380
P577
2014-12-01T00:00:00Z